Disomotide Withdrawn Phase 2 Trials for Melanoma Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Withdrawn | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00357461 | Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma |